Are you Dr. Castine?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 72 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
8595 Picardy Ave
Suite 400
Baton Rouge, LA 70809Phone+1 225-767-0822Fax+1 225-769-5424
Summary
- Dr. Michael Castine III, MD is an oncologist in Baton Rouge, Louisiana. He is currently licensed to practice medicine in Louisiana and Alabama. He is affiliated with Baton Rouge General Medical Center, Our Lady of the Lake Regional Medical Center, and Lane Regional Medical Center.
Education & Training
University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 1996 - 1999- University of Alabama Medical CenterResidency, Internal Medicine, 1992 - 1996
Louisiana State University School of Medicine in New OrleansClass of 1992
Certifications & Licensure
AL State Medical License 1993 - 2024
LA State Medical License 1999 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary Start of enrollment: 2009 Feb 01
- Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies Start of enrollment: 2013 Mar 14
Publications & Presentations
PubMed
- Case report of two siblings with type 2A von Willebrand disease involving a novel mutation within the calcium-binding site of the A2 domain of von Willebrand factor.Henry Palangdao Igid, Kyaw Zin Thein, Michael Castine, Donald P. Quick
Blood Coagulation & Fibrinolysis. 2019-06-01
Press Mentions
Unnecessary Medicare Advantage Denials: Harming Louisiana Patients, Crowding Our Emergency Departments, and Costing U.S. Providers BillionsSeptember 18th, 2024
Patient Longevity Will Be Key Driver in Hematology Market GrowthJune 12th, 2016
Professional Memberships
- Member
- Member
